Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis
A humanised IgG4 monoclonal antibody, Copellor (Ixekizumab) is designed to specifically target IL-17A, a protein that plays a role…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.